Circulating tumor cells (CTCs) are pivotal liquid biopsy (LB) biomarkers for breast cancer (BC), offering non-invasive insights into tumor progression and metastasis.
Despite their clinical promise, CTC detection remains technically challenging due to their extreme rarity in peripheral blood.
